IMGN - Immunogen Inc. (IMGN) CEO Mark Enyedy on Q2 2019 Results - Earnings Call Transcript
Immunogen, Inc. (IMGN)
Q2 2019 Results Earnings Conference Call
August 2, 2019 08:00 AM ET
Company Participants
Courtney O'Konek - Senior Director, Investor Relations and Corporate Communications
Mark Enyedy - President and Chief Executive Officer
Anna Berkenblit - Chief Medical Officer
Conference Call Participants
John Newman - Canaccord
John Scott - Cowen
Kennen MacKay - RBC Capital Markets
Andy Hsieh - William Blair
Aaron Welch - H.C. Wainwright
Biren Amin - Jeffries
Jonathan Chang - SVB Leerink
Michael Schmidt - Guggenheim Partners
Presentation
Operator
Good day, and welcome to the ImmunoGen Second Quarter 2019 Conference